Abstract
Microfragmented adipose tissue, commonly called MFAT, is a regenerative treatment made from a small amount of a patient’s own fat tissue. It may be considered for moderate-to-severe joint damage, cartilage injuries, chronic tendon problems, and larger partial soft-tissue tears that have not improved with basic conservative care. However, MFAT is not automatically better than platelet-rich plasma, or PRP, and it is not appropriate for every injury. This article explains when MFAT may be recommended after a motor vehicle accident or workplace injury, how it differs from PRP, and how integrative chiropractic care and rehabilitation may support recovery. It also explains the multidisciplinary approach used by Dr. Alexander Jimenez and Dr. Maria Guadalupe Cardenas at Injury Medical Clinic PA in El Paso, Texas.
What Is Microfragmented Adipose Tissue?
MFAT is prepared from a small amount of the patient’s own adipose (fat) tissue. The tissue is usually collected from the abdomen, side, thigh, or lower back through a small lipoaspiration procedure. It is then washed and mechanically divided into smaller pieces. The processed tissue is placed into the injured joint or soft tissue, often with ultrasound guidance.
MFAT keeps several natural parts of fat tissue together, including:
Structural tissue that may provide support
Blood-vessel-related cells
Signaling cells
Growth factors
Natural anti-inflammatory substances
A tissue framework that may support the healing environment
MFAT should not automatically be called a laboratory-grown stem cell treatment. It is more accurately described as minimally processed tissue taken from the patient’s own body. University of Iowa Health Care describes MFAT as a nonsurgical option used mainly for selected arthritic joints and tendon injuries (University of Iowa Health Care, n.d.).
When Is MFAT Recommended for Personal Injuries?
MFAT is usually not the first treatment provided after a car accident or workplace injury. New injuries often begin with diagnostic testing, activity changes, chiropractic care, rehabilitation, physical therapy, medication when appropriate, or a simpler injection such as PRP.
MFAT may be discussed when the injury is more complex, has caused greater tissue damage, or has not responded well to earlier treatment.
Moderate-to-Severe Joint Damage
MFAT is most often studied for knee osteoarthritis. It may be considered when an accident damages the joint surface or causes an existing arthritic condition to become painful.
Examples may include:
A knee striking the dashboard during a collision
A twisting knee injury at work
Post-traumatic knee arthritis
Cartilage wear made worse by an accident
Ongoing swelling, stiffness, and loss of movement
Pain that continues after therapy, PRP, or other injections
Clinical reviews suggest that MFAT may improve pain and function in selected people with knee osteoarthritis. However, evidence does not prove that MFAT fully regrows normal cartilage or reverses advanced arthritis (Hohmann et al., 2025; Li et al., 2023).
Cartilage Defects and Meniscus-Related Injuries
A motor vehicle or work accident can damage the smooth cartilage covering a joint. It can also injure the meniscus, which helps cushion and stabilize the knee.
MFAT may be considered when imaging shows:
A focal cartilage defect
Degenerative meniscus damage
Post-traumatic joint changes
Loss of cushioning inside the joint
Joint inflammation that continues after conservative treatment
The goal is usually to improve the joint environment, reduce symptoms, and support function. MFAT should not be presented as a guaranteed way to rebuild missing cartilage or repair a large mechanical tear (Carolina Nonsurgical Orthopedics, n.d.; Sellers, 2025).
Larger Partial Tendon or Ligament Tears
PRP is often considered for mild or moderate tendon injuries. MFAT may be discussed when the injury is larger, more chronic, or connected to joint degeneration.
Possible examples include:
A partial rotator cuff tear after a crash
A chronic patellar tendon injury
A partial Achilles tendon injury
A ligament injury that remains painful or unstable
A tendon problem that has not improved with therapy
A slow-healing soft-tissue injury with poor tissue quality
Evidence for MFAT in tendon and ligament care is less developed than the evidence for knee osteoarthritis. For this reason, the provider should review the examination, imaging, tear size, tissue quality, stability, and the patient’s recovery goals before recommending treatment (Ohlson, n.d.; University of Iowa Health Care, n.d.).
Injuries That Have Not Improved With Conservative Care
MFAT may also be considered when a patient has completed a reasonable period of conservative care but still has major pain or loss of function.
Earlier care may include:
Chiropractic treatment
Physical therapy or rehabilitation
Corrective exercises
Activity and work modifications
Bracing
Anti-inflammatory care
PRP or other basic injections
A structured home exercise program
A lack of improvement does not automatically mean MFAT is needed. The care team should first confirm the diagnosis. Continued pain may come from an untreated fracture, nerve injury, unstable joint, full-thickness tear, severe spinal compression, or another problem that requires a different type of care.
Is MFAT Better Than PRP?
MFAT is more involved than PRP. PRP requires a blood draw, while MFAT requires a small fat-harvesting procedure in addition to the injection. This means MFAT normally involves more preparation, greater cost, and soreness at both the collection and treatment sites.
PRP may be considered first when the patient has:
Mild-to-moderate joint degeneration
A smaller partial tendon tear
Tendinopathy without major tissue loss
A new ligament sprain
A condition with reasonable natural healing ability
MFAT may be discussed when there is:
More advanced joint degeneration
A larger cartilage defect
Greater loss of tissue quality
A more complex partial soft-tissue tear
Persistent symptoms after PRP
A need for a more structural tissue product
Research does not show that MFAT is always better. A randomized trial found that both PRP and MFAT improved patient-reported knee osteoarthritis outcomes, with no major difference between them at 12 months. Other reviews have also found similar results, while one meta-analysis suggested that PRP may provide better long-term pain relief in some patients (Baria et al., 2024; Hohmann et al., 2025; Ye et al., 2024).
The treatment should therefore be selected according to the injury—not according to which procedure sounds more advanced.
When MFAT May Not Be the Right Choice
MFAT is not a replacement for emergency, surgical, or neurological care. It may not be appropriate when a patient has:
An unstable fracture
A complete tendon or ligament rupture
Severe joint instability
An active infection
A major wound near the treatment area
Progressive muscle weakness from nerve compression
Advanced joint destruction that requires replacement
A medical condition that makes the procedure unsafe
Unrealistic expectations about tissue regrowth
Patients should also understand that regenerative treatments are not guaranteed cures. The U.S. Food and Drug Administration warns that regenerative medicine products have not been approved to treat orthopedic conditions such as osteoarthritis, tendonitis, back pain, knee pain, or shoulder pain. Patients should ask exactly what is being used, how it is processed, who performs the procedure, and how the treatment is regulated (U.S. Food and Drug Administration, 2021).
How Integrative Chiropractic Care Fits With MFAT
MFAT may support the biological side of healing, but it does not correct every mechanical problem created by an accident. A damaged knee may still be overloaded because of poor hip movement. A shoulder tendon may remain irritated because the shoulder blade is not moving correctly. An ankle injury may continue to hurt because the patient has poor balance and an uneven walking pattern.
Integrative chiropractic care may help address these mechanical problems through:
Joint and spinal mobility care
Gentle manual therapy
Soft-tissue treatment
Posture correction
Movement testing
Balance and coordination exercises
Progressive strengthening
Work and lifting education
A gradual return-to-activity plan
There is limited direct research testing MFAT and chiropractic care as one combined treatment. They are used together because they have different roles. MFAT may support the tissue environment, while chiropractic care and rehabilitation may improve movement and reduce repeated stress on the healing area (Jimenez, 2026a, 2026b).
Proper Treatment Timing Matters
Chiropractic care after MFAT should be carefully timed.
Before the Procedure
The team may evaluate joint motion, posture, muscle weakness, balance, walking patterns, work demands, and compensating movements. These findings create a baseline for measuring progress.
Early Protection Phase
During the first stage, the patient should follow the procedure provider’s instructions. Aggressive treatment directly over the injection or fat-harvest area may need to be avoided. Gentle movement in other regions may be used when medically appropriate.
Controlled Rehabilitation Phase
As soreness decreases, the patient may begin a structured program that includes:
Gentle range-of-motion exercises
Muscle activation
Balance training
Isometric exercises
Light resistance
Gradual weight-bearing
Progressive strengthening
Return-to-Function Phase
The final stage focuses on daily activities, driving, lifting, work tasks, exercise, and sports. Progress should be based on function, not simply the number of days since the procedure.
A Multidisciplinary Model in El Paso
At Injury Medical Clinic PA in El Paso, clinic materials describe a multidisciplinary model involving Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, and Dr. Maria Guadalupe Cardenas, MD.
The clinic identifies Dr. Cardenas as a board-certified internal medicine physician with more than 40 years of experience. The clinic materials list her as medical director and collaborative physician, Texas Medical License #J2933, and NPI #1164426749. Her role includes medical direction, medication review, health-risk evaluation, laboratory interpretation, medical screening, and referrals when needed.
Dr. Jimenez provides the chiropractic, functional, and rehabilitation parts of the plan. His work includes biomechanical examinations, chiropractic care, neuromuscular training, functional medicine support, personal injury documentation, and return-to-function rehabilitation.
Together, the team may coordinate:
Medical oversight
Chiropractic treatment
Functional medicine
Personal injury care
Diagnostic imaging
Rehabilitation
Nutrition and lifestyle support
Progress examinations
Referrals to outside specialists
This type of coordinated model allows each professional to work within the limits of their license while sharing information about the patient’s recovery (Jimenez, 2026a).
Clinical Observations From Dr. Alexander Jimenez
In his published clinical framework, Dr. Jimenez reports that lasting recovery often requires more than an injection. His clinical observations suggest that biological treatment works best when the team also addresses joint motion, muscle control, strength, nutrition, systemic inflammation, sleep, and the patient’s daily physical demands.
He has also observed the importance of identifying the true pain generator. Pain may come from a tendon, joint, ligament, nerve, muscle, or a combination of structures. MFAT should be targeted only after the injured area has been clearly identified through an examination and appropriate imaging.
These are clinical observations and should not be confused with controlled clinical-trial evidence. They support an individualized care framework but do not guarantee that every patient will experience the same result (Jimenez, 2026a, 2026b).
Final Takeaway
MFAT may be recommended after a motor vehicle accident or work injury when there is moderate-to-severe joint damage, a cartilage defect, a larger partial soft-tissue injury, or a condition that has not improved with conservative treatment. The strongest clinical evidence currently involves knee osteoarthritis, while evidence for tendon, ligament, and other personal injuries is still developing.
MFAT is not automatically better than PRP, does not guarantee cartilage regrowth, and cannot replace surgery when an injury requires surgical repair. The best results are more likely when the patient receives a clear diagnosis, proper medical screening, image-guided treatment, carefully timed chiropractic care, and progressive rehabilitation.
References
Baria, M. R., et al. (2024). Microfragmented adipose tissue is equivalent to platelet-rich plasma for knee osteoarthritis at 12 months posttreatment. Orthopaedic Journal of Sports Medicine.
Carolina Nonsurgical Orthopedics. (n.d.). PRP vs. MFAT cell therapy: Which regenerative treatment is right for you?
Close, M. (2026, February 26). Comparing PRP, BMAC, and MFAT: Choosing the right regenerative treatment. Sports Medicine of the Rockies.
Hohmann, E., et al. (2025). Micro-fragmented aspirated tissue injection therapy for symptomatic knee osteoarthritis: A systematic review.
Jimenez, A. (2026a). Regenerative chiropractic care for musculoskeletal pain relief.
Jimenez, A. (2026b). How regenerative medicine and chiropractic care work together.
Li, W., et al. (2023). Autologous microfragmented adipose tissue in the treatment of knee osteoarthritis: A systematic review and meta-analysis.
Ohlson, B. (n.d.). Microfragmented adipose tissue therapy.
Sellers, T. (2025, November 3). Micro-fragmented adipose tissue: A treatment for knee arthritis.
University of Iowa Health Care. (n.d.). Microfragmented adipose tissue.
U.S. Food and Drug Administration. (2021, June 3). Important patient and consumer information about regenerative medicine therapies.
Ye, X., et al. (2024). Microfragmented adipose tissue versus platelet-rich plasma for knee osteoarthritis: A meta-analysis.
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified in Internal Medicine)
Medical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
